Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 10, 2017 10:35am
128 Views
Post# 26225492

RE:RE:RE:RE:Kumbaya.......

RE:RE:RE:RE:Kumbaya.......I would personally like to thank BigDolphin for all of his/her brilliant deductive reasoning regarding the business, risk,  science and perspectives on the future of RVX, Zenith and epigenetic science that have enlightened so many of us with his/her posts. We are truly blessed to have such value added to this board.

This type of great insight has been of such great value. Providing us with perspectives on trials, timelines and case studies of other biotechs surely helps us and other readers shape our thoughts.

Helping us understand who might be suitors and what their particular interests would be in Zenith/RVX is of great value and I thank you for your efforts and insights. Much appreciated!

Thank you also for your insights on the science and the risk of investing in break through scientific endevours like RVX and Zenith.

I thank you for your postivie insights and your ability to uncover insights others have not seen and thus to enlighten us but also for the well reasoned critical thinking you provide.

In terms of your objectivity...what can I say other than thank you.

Since I am on ignore I'm sure I will not see a reply so perhaps others can pass along my great appreciation of BigDolphin's brilliant contributions to this board!

Cheers
Toinv
Bullboard Posts